Related references
Note: Only part of the references are listed.Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype
N. Pallet et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Loss of Pediatric Kidney Grafts During the High-Risk Age Window: Insights From Pediatric Liver and Simultaneous Liver-Kidney Recipients
K. J. Van Arendonk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction
G. Gupta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients
Donald E. Hricik et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Through a Glass Darkly: Seeking Clarity in Preventing Late Kidney Transplant Failure
Mark D. Stegall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients
Emilie Dugast et al.
IMMUNOLOGICAL REVIEWS (2014)
15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation
Joke I. Roodnat et al.
TRANSPLANTATION (2014)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation results from an aborted trial
Anders Asberg et al.
CLINICAL TRANSPLANTATION (2013)
Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients
T. Akimova et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients
Wai H. Lim et al.
CLINICAL TRANSPLANTATION (2012)
Organ Transplantation 3 Diagnosis and prevention of chronic kidney allograft loss
Brian J. Nankivell et al.
LANCET (2011)
Two Hundred Living Donor Kidney Transplantations Under Alemtuzumab Induction and Tacrolimus Monotherapy: 3-Year Follow-Up
H. P. Tan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation
Joanna Ashton-Chess et al.
TRANSPLANTATION (2007)
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR study
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study
D Abramowicz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review
JA Butler et al.
TRANSPLANTATION (2004)
Immunosuppressive drugs for kidney transplantation
PF Halloran
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination
TA Gonwa et al.
TRANSPLANTATION (2002)
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy:: A randomized, prospective, multicenter study
PJHS Gregoor et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Medical progress - Strategies to improve long-term outcomes after renal transplantation
M Pascual et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation
F Vincenti et al.
TRANSPLANTATION (2001)
Share Paper
